NCT07213908 Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
| NCT ID | NCT07213908 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital Los Angeles |
| Condition | Sleep |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,320 participants |
| Start Date | 2026-03-31 |
| Primary Completion | 2030-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,320 participants in total. It began in 2026-03-31 with a primary completion date of 2030-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to conduct a comparative effectiveness trial that will evaluate two school-based interventions to improve adolescent sleep health: the standard Sleep Health Education (SHE) and a stepped care version of the Transdiagnostic Sleep and Circadian intervention (TS-C-STEP). The main questions it aims to answer \[is/are\]: * TS-C-STEP will yield superior outcomes relative to SHE at post-treatment and up to 12 months following treatment. * In this large and diverse sample, vulnerable subgroups (e.g. socioeconomically disadvantaged, racial, ethnic, rural, and youth with comorbid learning and/or mental health conditions) will experience greater benefits from TS-C-STEP compared to SHE on primary and secondary outcomes. Researchers will compare sleep quality to determine which intervention is most effective.
Eligibility Criteria
Inclusion Criteria: * Age 12-18 years old * Sleep health problem (i.e. insomnia, evening circadian preference, short sleep duration, poor sleep quality) * Able to participate in a general education classroom. Exclusion Criteria: * Previous participation in the study; * Symptoms or illness that precludes informed consent or engagement in study procedures ; youth not fluent in English, parent not fluent in English, or Spanish.
Contact & Investigator
Lauren Asarnow,, PhD
PRINCIPAL INVESTIGATOR
Children's Hospital Los Angeles
Frequently Asked Questions
Who can join the NCT07213908 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 18 Years, studying Sleep. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07213908 currently recruiting?
Yes, NCT07213908 is actively recruiting participants. Contact the research team at madeyeba@chla.usc.edu for enrollment information.
Where is the NCT07213908 trial being conducted?
This trial is being conducted at Los Angeles, United States, Columbus, United States.
Who is sponsoring the NCT07213908 clinical trial?
NCT07213908 is sponsored by Children's Hospital Los Angeles. The principal investigator is Lauren Asarnow,, PhD at Children's Hospital Los Angeles. The trial plans to enroll 1,320 participants.